Advances diabetes and obesity programs with icovamenib demonstrating durable 52-Week Phase II data and with BMF-650, Biomea’s next-generation, ...

As cyber-threats evolve, so must our mindset. In his recent article at SC Media, Jim Routh (an esteemed Institute for ...

Ankyra Therapeutics, a clinical-stage biotechnology company pioneering anchored drug conjugate technology for cancer and other diseases, today announced the publication online of Part 1 results from ...

A Study of the Present Situation of Occupational Well-Being among Kindergarten Teachers —Based on OECD “Teachers’ Well-Being: Data Collection and Analysis Framework”. Creative Education, 16, 1716-1726 ...

Findings further demonstrate the effectiveness of Roche's approved medicines in advancing treatment standards for people with blood disorders Data from innovative pipeline signals progress ...

Basel, 3 November 2025 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that it will showcase 46 abstracts, including 12 oral presentations, from its industry-leading haematology portfolio at the ...

Takeda (TSE:4502/NYSE:TAK) announced the completion of the 7-year pivotal Phase 3 Tetravalent Immunization against Dengue ...

Artificial intelligence is one of the fastest-growing and highest-paying fields today. The continued digitization of ...

I 'm a big fan of Python for data analysis, but even I get curious about what else is available. R has long been the go-to ...

APL is fusing its analytic and cutting-edge AI capabilities into a forward-leaning incubator, known as GenWar Lab, that ...

Physical therapy is routinely recommended for knee pain attributed to a degenerative meniscal tear, but its efficacy has not ...